AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Find out when funds are available after a deposit, including standard windows and factors that can affect arrival times.
21,612 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Bitcoin teeters near a critical support zone after a pullback from last week’s highs. This bitcoin price analysis: co...
As AMD prepares to report its second-quarter results, a bullish outlook centered on AI demand could dominate the conv...
An academic paper analyzes UWM's 2021 broker ultimatum tied price and finds rivals shaved an average of 5 basis point...
Oracle stock down 60% from its peak doesn’t tell the whole story. This article digs into the AI cloud momentum fuelin...
As the AI boom strong powers data-center growth, memory stocks are slipping. Analysts point to cyclical supply dynami...
Apollo-owned Michaels is reshaping its business by absorbing assets from rival bankruptcies, expanding party and fabr...
Firms across tech and logistics are testing cheaper Chinese AI models as U.S. rivals grow pricier. The move spans sta...
SOXL surged earlier this year but pulled back sharply in the last month. Two pressure points that will shape its next...
Two giants in chip-design software compete for your next tech stock buy. This guide breaks down Cadence Design System...
Mortgage applications fell as the 30-year fixed rate climbed to 6.65%, the highest since August 2025. Refinance deman...
A Fed official signaled no rescue for crypto amid stress, pushing Bitcoin, Ethereum, and XRP into a fresh round of vo...